The stagnant share of foreign investment in insurance companies
has prompted the government to defer raising the limit in the sector to 74 per cent from 49 per cent now.
As the table shows, there is headroom for foreign partners in both the life and non-life sectors within the current limits. This is the list shared by the sector regulator, the Insurance Regulatory Authority of India (IRDAI), with the finance ministry before the Budget.
Both the finance ministry and IRDAI
had talks on this with the companies in the run up to Budget 2020-21.
“We did get representations to raise the limit, but the data does not support those,” said a senior official of the sector. There have also been strong representations from US business interests supporting the move to raise the insurance foreign investment limit.
After the Budget made no mention of it, the influential US-India Strategic Partnership Forum expressed disappointment.
Speaking at a recent event on the India-USA trade dialogue, Sanjay Chadha, additional secretary, ministry of commerce, said raising the foreign investment limit was a key issue of difference between New Delhi and Washington DC.
As of March last year, in the life insurance sector, for instance, against the 49 per cent limit of permissible foreign investment, the aggregate foreign investment is 35.49 per cent.
It is almost unchanged from what it was a year ago. Of the 23 private sector companies in the sector, 12 have space for more investment in the sector. This includes leaders like Bajaj Allianz Life, HDFC Life, and ICICI Prudential.
In the case of general, reinsurance, and standalone health insurance companies
the utilisation percentage of the space for foreign investment is worse. The aggregate space for foreign investment has been utilised to less than half the permissible limit. It has gone down from the level of March 2018, when it was 25.42 per cent, to 23.66 per cent.
Again, a perusal of the list of the 28 private-sector companies shows only six have used up their limit of 49 per cent. These are Max Bupa, Cigna, and Aditya Birla among health insurers and Bharti Axa, Iffco-Tokio and Raheja QBE.